Sarcoidosis is a multi-systemic disease of unknown etiology with a clinical presentation ranging from asymptomatic disease to organ failure. While some patients with sarcoidosis have spontaneous disease remission, others may require treatment for symptom management, organ involvement, and/or risk reduction of disease progression. Data on sarcoidosis treatment in the U.S. is limited and inconsistent, with […]
Boston-based research team will focus on understanding how dysfunctional lung epithelial cells initiate and perpetuate pulmonary fibrosis.